A multinational phase II trial of bevacizumab with low-dose interferon-α2a as first-line treatment of metastatic renal cell carcinoma: BEVLiN
Titel:
A multinational phase II trial of bevacizumab with low-dose interferon-α2a as first-line treatment of metastatic renal cell carcinoma: BEVLiN
Auteur:
Melichar, B. Bracarda, S. Matveev, V. Alekseev, B. Ivanov, S. Zyryanov, A. Janciauskiene, R. Fernebro, E. Mulders, P. Osborne, S. Jethwa, S. Mickisch, G. Gore, M. van Moorselaar, R.J.A. Staehler, M. Magne, N. Bellmunt, J.